These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32827198)

  • 1. Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin.
    Del Boz J; García-Souto F; Rivas-Ruiz F; Polo-Padillo J
    Dermatol Ther; 2020 Nov; 33(6):e14210. PubMed ID: 32827198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival study of treatment adherence by patients given oral oxibutynin for hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; García-Montero P; García-Harana C; Rivas Ruiz F; de Troya-Martín M
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1034-1037. PubMed ID: 29220103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjusting oral glycopyrrolate medication for hyperhidrosis to reflect seasonal temperature variations.
    Garcia-Souto F; Del Boz J; Polo-Padillo J
    Dermatol Ther; 2020 Nov; 33(6):e14249. PubMed ID: 32860330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance of oral oxybutynin in the treatment of hyperhidrosis.
    Del Boz Gonzalez J; Rodríguez Barón D; Millán-Cayetano JF; de Troya Martin M
    Dermatol Ther; 2020 Nov; 33(6):e14197. PubMed ID: 32794595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjusting oral oxybutynin medication for hyperhidrosis to reflect seasonal temperature variations.
    Del Boz J; Millán-Cayetano JF; García-Montero P; García-Harana C; Rivas-Ruiz F; de Troya-Martín M
    Dermatol Ther; 2018 Jul; 31(4):e12615. PubMed ID: 29740900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
    Prouty ME; Fischer R; Liu D
    Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
    Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M
    Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700
    [No Abstract]   [Full Text] [Related]  

  • 8. Craniofacial hyperhidrosis: Clinical characteristics and response to treatment in a cohort of 97 patients treated with oral oxybutynin.
    Garcia-Souto F; Del Boz J; Colmenero-Sendra M; Polo-Padillo J
    Dermatol Ther; 2021 Jan; 34(1):e14658. PubMed ID: 33301207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxybutynin as an alternative treatment for hyperhidrosis.
    Delort S; Marchi E; Corrêa MA
    An Bras Dermatol; 2017; 92(2):217-220. PubMed ID: 28538882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized Dosing of Oral Oxybutynin for the Treatment of Primary Focal Hyperhidrosis in Children and Teenagers.
    Del Boz J; Millán-Cayetano JF; Blázquez-Sánchez N; de Troya M
    Pediatr Dermatol; 2016 May; 33(3):327-31. PubMed ID: 27122197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.
    Kim WO; Kil HK; Yoon KB; Yoo JH
    Acta Derm Venereol; 2010 May; 90(3):291-3. PubMed ID: 20526549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life experience with oral oxybutynin long-term continuous therapy in severe hyperhidrosis and systematic review of the literature.
    Briatico G; Pampena R; Fulgione E; Babino G; Giorgio CM; D'Ambra I; Caccavale S; Longo C; Argenziano G
    Dermatol Ther; 2021 Mar; 34(2):e14832. PubMed ID: 33527699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
    J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial study of transdermal oxybutynin for treating hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; Toledo-Pastrana T; Nieto-Guindo M; García-Montero P; de Troya-Martín M
    J Dermatol; 2017 Jun; 44(6):717-720. PubMed ID: 28106275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
    Walling HW
    J Am Acad Dermatol; 2012 Mar; 66(3):387-92. PubMed ID: 21820204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral oxybutynin for the treatment of hyperhidrosis: outcomes after one-year follow-up.
    Millán-Cayetano JF; Del Boz J; Rivas-Ruiz F; Blázquez-Sánchez N; Hernández Ibáñez C; de Troya-Martín M
    Australas J Dermatol; 2017 May; 58(2):e31-e35. PubMed ID: 27029500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial.
    Schollhammer M; Brenaut E; Menard-Andivot N; Pillette-Delarue M; Zagnoli A; Chassain-Le Lay M; Sassolas B; Jouan N; Le Ru Y; Abasq-Thomas C; Greco M; Penven K; Roguedas-Contios AM; Dupré-Goetghebeur D; Gouedard C; Misery L; Le Gal G
    Br J Dermatol; 2015 Nov; 173(5):1163-8. PubMed ID: 26114588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life before hyperhidrosis treatment as a predictive factor for oxybutynin treatment outcomes in palmar and axillary hyperhidrosis.
    Wolosker N; Krutman M; Teivelis MP; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 May; 28(4):970-6. PubMed ID: 24333527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis].
    Maillard H; Fenot M; Bara C; Célérier P
    Ann Dermatol Venereol; 2011 Oct; 138(10):652-6. PubMed ID: 21978500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.